Production (Stage)
Encompass Health Corporation
EHC
$118.90
$0.290.24%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.21% | 11.91% | 11.15% | 10.86% | 11.40% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.21% | 11.91% | 11.15% | 10.86% | 11.40% |
| Cost of Revenue | 9.94% | 11.41% | 11.05% | 10.37% | 10.02% |
| Gross Profit | 13.02% | 12.63% | 11.30% | 11.55% | 13.40% |
| SG&A Expenses | 1.70% | 3.29% | 7.13% | 11.54% | 24.18% |
| Depreciation & Amortization | 10.06% | 9.38% | 9.21% | 7.14% | 12.21% |
| Other Operating Expenses | 11.09% | 10.17% | 9.40% | 8.55% | 6.59% |
| Total Operating Expenses | 9.63% | 10.54% | 10.39% | 9.90% | 10.34% |
| Operating Income | 19.83% | 19.55% | 15.37% | 16.25% | 17.51% |
| Income Before Tax | 26.65% | 23.45% | 20.18% | 21.35% | 31.29% |
| Income Tax Expenses | 10.75% | 13.62% | 18.05% | 21.71% | 27.86% |
| Earnings from Continuing Operations | 31.05% | 26.19% | 20.75% | 21.25% | 32.28% |
| Earnings from Discontinued Operations | 83.74% | 76.67% | -134.00% | 44.59% | -29.47% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -42.88% | -26.94% | -19.98% | -17.01% | -14.10% |
| Net Income | 31.29% | 29.46% | 19.39% | 27.27% | 38.94% |
| EBIT | 19.83% | 19.55% | 15.37% | 16.25% | 17.51% |
| EBITDA | 17.22% | 16.78% | 13.70% | 13.74% | 16.05% |
| EPS Basic | 30.80% | 28.90% | 18.90% | 26.77% | 38.39% |
| Normalized Basic EPS | 17.22% | 24.04% | 22.37% | 25.34% | 41.70% |
| EPS Diluted | 30.59% | 28.28% | 18.30% | 26.09% | 37.77% |
| Normalized Diluted EPS | 17.22% | 23.45% | 21.71% | 24.57% | 40.85% |
| Average Basic Shares Outstanding | 0.50% | 0.43% | 0.35% | 0.33% | 0.30% |
| Average Diluted Shares Outstanding | 0.57% | 0.91% | 0.89% | 0.94% | 0.92% |
| Dividend Per Share | 10.00% | 6.67% | 3.33% | 0.00% | -17.81% |
| Payout Ratio | -0.19% | -0.20% | -0.16% | -0.35% | -0.49% |